Evaluation of Bioavailability of Diclofenac Dermal Products
Status:
Completed
Trial end date:
2020-05-15
Target enrollment:
Participant gender:
Summary
The study will utilize already FDA-approved marketed diclofenac products in healthy adults to
generate data for establishing rate of drug delivery comparisons between diclofenac epolamine
patches and diclofenac sodium solution in healthy adults and to determine skin
concentrations.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore